Vertex Pharmaceuticals Inc
(NASDAQ:VRTX)
$344.40
-3.34[-0.96%]
Last update: 1:16PM (Delayed 15-Minutes)
Get Real Time Here
$347.74
3.3400[0.97%]
Open346.760Close-
Vol / Avg.256.720K / 979.623KMkt Cap88.888B
Day Range342.620 - 347.74052 Wk Range282.210 - 367.000

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Vertex Pharmaceuticals Stock (NASDAQ:VRTX) Earnings Dates and Earning Calls

Vertex Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Oct 26

EPS Estimate

$3.970

Quarterly Revenue Estimate

$2.5B

Annual Revenue (as of Jun 30)

$9.5B

Earnings History

Analyze the earnings history of Vertex Pharmaceuticals using advanced sorting and filters.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals (VRTX) is scheduled to report earnings on October 26, 2023. The last reported earnings were for reported on August 1, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Vertex Pharmaceuticals (NASDAQ:VRTX)?

A

The Actual EPS was $3.89, which beat the estimate of $3.85.

Q

What were Vertex Pharmaceuticals’s (NASDAQ:VRTX) revenues?

A

The Actual Revenue was $2.5B, which beat the estimate of $2.4B.

Browse earnings estimates, EPS, and revenue on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2023 Benzinga | All Rights Reserved